Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
34
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| OConnor David Justin | See Remarks | 1 | $0 | $0 | 2023-03-03 |
| Charles Ian Hunter | Director, 10% Owner | 1 | $0 | $0 | 2023-03-03 |
| McPherron Meredith Lazo | Director | 1 | $0 | $0 | 2023-03-03 |
| Smith Jared T | Director | 1 | $0 | $0 | 2023-03-03 |
| ARCTOS NORTHSTAR ACQUISITION HOLDINGS, LLC | 10% Owner | 1 | $0 | $0 | 2023-03-03 |
| Gutierrez Xavier A | Director | 1 | $0 | $0 | 2023-03-03 |
| Collins Tomago | Director | 1 | $0 | $0 | 2023-03-03 |
| Bell Graeme | Executive VP and CFO | 14 | $0 | $74.6K | 2016-06-24 |
| Sullivan Ryan T | Sr. VP and General Counsel | 24 | $0 | $1.56M | 2016-06-24 |
| Zane Lee | VP, Clinical Dev & Interim CMO | 57 | $0 | $5.36M | 2016-06-24 |
| Shapiro Lucy | Director | 58 | $0 | $12.72M | 2016-06-24 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 31 | $0 | $5.13M | 2016-06-24 |
| Leonard Keith R | Director | 9 | $0 | $897.3K | 2016-06-24 |
| Hove Anders D | Director, 10% Owner | 48 | $0 | $190.53M | 2016-06-24 |
| WIERENGA WENDALL | Director | 6 | $0 | $0 | 2016-06-24 |
| BERNS PAUL L | President and CEO | 55 | $0 | $16.52M | 2016-06-24 |
| RIEFLIN WILLIAM JL | Director | 18 | $0 | $0 | 2016-06-24 |
| LESCHLY MARK | Director | 14 | $0 | $294.0K | 2016-06-24 |
| Maples Kirk R | SVP, Program Management | 80 | $0 | $4.33M | 2015-06-01 |
| Plattner Jacob j | Senior VP, Research | 23 | $0 | $3.30M | 2015-05-15 |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | 19 | $0 | $3.89M | 2015-05-14 |
| Parker Geoffrey M. | Senior Vice President and CFO | 25 | $1.49M | $0 | 2015-03-23 |
| Chanda Sanjay | VP, Int. Head of Drug Dev. | 25 | $0 | $642.5K | 2015-03-04 |
| KLINGENSTEIN PAUL H | Director | 3 | $0 | $0 | 2014-05-29 |
| PERRY DAVID P | President and CEO | 18 | $0 | $3.28M | 2014-03-05 |
| RHO VENTURES IV LP | 10% Owner | 3 | $0 | $0 | 2014-02-03 |
| ROBERTS BRYAN E | 10% Owner | 3 | $0 | $2.27M | 2013-11-15 |
| RHO CAPITAL PARTNERS VERWALTUNGS GMBH | 10% Owner | 2 | $0 | $0 | 2013-10-24 |
| VENROCK HEALTHCARE CAPITAL PARTNERS LP | 10% Owner | 1 | $0 | $121.4K | 2012-09-20 |
| Venrock Partners Management V, LLC | 10% Owner | 3 | $0 | $121.4K | 2012-09-20 |
| VENROCK ASSOCIATES V LP | 10% Owner | 1 | $0 | $227.8K | 2012-09-14 |
| Venrock Management IV, LLC | 10% Owner | 3 | $0 | $393.8K | 2012-09-14 |
| VEF Management IV, LLC | 10% Owner | 2 | $0 | $0 | 2012-07-02 |
| Heyman Irwin A | Senior VP, Drug Development | 1 | $0 | $0 | 2012-03-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| ARCTOS NORTHSTAR ACQUISITION H | 10% Owner | D To issuer deriv | 2023-03-03 | 2023-03-07 | 7,806,249 | — | $0 | 1 | SEC↗ |
| Gutierrez Xavier A | Director | D To issuer deriv | 2023-03-03 | 2023-03-07 | 25,000 | — | $0 | 0 | SEC↗ |
| McPherron Meredith Lazo | Director | D To issuer deriv | 2023-03-03 | 2023-03-07 | 25,000 | — | $0 | 0 | SEC↗ |
| Charles Ian Hunter | Director, 10% Owner | D To issuer deriv | 2023-03-03 | 2023-03-07 | 7,806,249 | — | $0 | 1 | SEC↗ |
| Smith Jared T | Director | D To issuer deriv | 2023-03-03 | 2023-03-07 | 25,000 | — | $0 | 0 | SEC↗ |
| OConnor David Justin | See Remarks | D To issuer deriv | 2023-03-03 | 2023-03-07 | 7,806,249 | — | $0 | 1 | SEC↗ |
| Collins Tomago | Director | D To issuer deriv | 2023-03-03 | 2023-03-07 | 25,000 | — | $0 | 0 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | D To issuer deriv | 2016-06-24 | 2016-06-24 | 25,299 | — | $0 | 0 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | D To issuer deriv | 2016-06-24 | 2016-06-24 | 6,930 | — | $0 | 0 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | D To issuer deriv | 2016-06-24 | 2016-06-24 | 5,000 | — | $0 | 0 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | D To issuer deriv | 2016-06-24 | 2016-06-24 | 61,000 | — | $0 | 0 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | D To issuer deriv | 2016-06-24 | 2016-06-24 | 28,400 | — | $0 | 0 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | D To issuer deriv | 2016-06-24 | 2016-06-24 | 6,350 | — | $0 | 0 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | D To issuer deriv | 2016-06-24 | 2016-06-24 | 6,250 | — | $0 | 0 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | D To issuer deriv | 2016-06-24 | 2016-06-24 | 30,000 | — | $0 | 0 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | D To issuer deriv | 2016-06-24 | 2016-06-24 | 24,360 | — | $0 | 0 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | D To issuer deriv | 2016-06-24 | 2016-06-24 | 31,623 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | President and CEO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 394,000 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | President and CEO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 14,584 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | President and CEO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 12,890 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | President and CEO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 73,788 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | President and CEO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 84,100 | — | $0 | 0 | SEC↗ |
| Bell Graeme | Executive VP and CFO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 25,299 | — | $0 | 0 | SEC↗ |
| Bell Graeme | Executive VP and CFO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 28,793 | — | $0 | 0 | SEC↗ |
| Bell Graeme | Executive VP and CFO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 5,000 | — | $0 | 0 | SEC↗ |
| Bell Graeme | Executive VP and CFO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,004 | — | $0 | 0 | SEC↗ |
| Bell Graeme | Executive VP and CFO | D To issuer deriv | 2016-06-24 | 2016-06-24 | 8,008 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 22,136 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 24,360 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 47,000 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 3,849 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 30,000 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 12,957 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 80,000 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 27,661 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 33,239 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,375 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer deriv | 2016-06-24 | 2016-06-24 | 6,350 | — | $0 | 0 | SEC↗ |
| WIERENGA WENDALL | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 27,000 | — | $0 | 0 | SEC↗ |
| WIERENGA WENDALL | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,096 | — | $0 | 0 | SEC↗ |
| Leonard Keith R | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,096 | — | $0 | 0 | SEC↗ |
| Leonard Keith R | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 18,000 | — | $0 | 0 | SEC↗ |
| LESCHLY MARK | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| LESCHLY MARK | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| LESCHLY MARK | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 24,000 | — | $0 | 0 | SEC↗ |
| LESCHLY MARK | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 30,000 | — | $0 | 0 | SEC↗ |
| LESCHLY MARK | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,096 | — | $0 | 0 | SEC↗ |
| LESCHLY MARK | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,403 | — | $0 | 0 | SEC↗ |
| Shapiro Lucy | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 7,500 | — | $0 | 0 | SEC↗ |
| Shapiro Lucy | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 813 | — | $0 | 0 | SEC↗ |
| Shapiro Lucy | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,096 | — | $0 | 0 | SEC↗ |
| Hove Anders D | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 12,500 | — | $0 | 0 | SEC↗ |
| Hove Anders D | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| Hove Anders D | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 30,000 | — | $0 | 0 | SEC↗ |
| Hove Anders D | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,096 | — | $0 | 0 | SEC↗ |
| Hove Anders D | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| Hove Anders D | Director | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | D To issuer | 2016-06-24 | 2016-06-24 | 68,985 | $99.25 | $6.85M | 0 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | D To issuer | 2016-06-24 | 2016-06-24 | 30,132 | $99.25 | $2.99M | 0 | SEC↗ |
| BERNS PAUL L | President and CEO | D To issuer | 2016-06-24 | 2016-06-24 | 231,311 | $99.25 | $22.96M | 0 | SEC↗ |
| Bell Graeme | Executive VP and CFO | D To issuer | 2016-06-24 | 2016-06-24 | 10,488 | $99.25 | $1.04M | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | D To issuer | 2016-06-24 | 2016-06-24 | 44,194 | $99.25 | $4.39M | 0 | SEC↗ |
| WIERENGA WENDALL | Director | D To issuer | 2016-06-24 | 2016-06-24 | 794 | $99.25 | $78.8K | 0 | SEC↗ |
| Leonard Keith R | Director | D To issuer | 2016-06-24 | 2016-06-24 | 794 | $99.25 | $78.8K | 0 | SEC↗ |
| LESCHLY MARK | Director | D To issuer | 2016-06-24 | 2016-06-24 | 794 | $99.25 | $78.8K | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | D To issuer | 2016-06-24 | 2016-06-24 | 89,000 | $99.25 | $8.83M | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | D To issuer | 2016-06-24 | 2016-06-24 | 853 | $99.25 | $84.7K | 0 | SEC↗ |
| Shapiro Lucy | Director | D To issuer | 2016-06-24 | 2016-06-24 | 794 | $99.25 | $78.8K | 0 | SEC↗ |
| Hove Anders D | Director | D To issuer | 2016-06-24 | 2016-06-24 | 33,886 | $99.25 | $3.36M | 0 | SEC↗ |
| Bell Graeme | Executive VP and CFO | S Sale | 2016-06-01 | 2016-06-03 | 751 | $99.28 | $74.6K | 10,255 | SEC↗ |
| Leonard Keith R | Director | M Exercise deriv | 2016-05-23 | 2016-05-24 | 9,000 | — | $0 | 18,000 | SEC↗ |
| Leonard Keith R | Director | S Sale | 2016-05-23 | 2016-05-24 | 9,000 | $99.70 | $897.3K | 794 | SEC↗ |
| Leonard Keith R | Director | M Exercise | 2016-05-23 | 2016-05-24 | 9,000 | $14.22 | $128.0K | 9,794 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-05-16 | 2016-05-18 | 81,631 | $100.60 | $8.21M | 272,250 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-05-16 | 2016-05-18 | 72,385 | $98.93 | $7.16M | 0 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-05-16 | 2016-05-18 | 199,865 | $99.41 | $19.87M | 72,385 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | S Sale | 2016-04-29 | 2016-04-29 | 3,125 | $66.33 | $207.3K | 30,132 | SEC↗ |
| Hove Anders D | Director | C Conversion deriv | 2016-04-14 | 2016-04-15 | 0 | — | $0 | 0 | SEC↗ |
| Hove Anders D | Director | C Conversion | 2016-04-14 | 2016-04-15 | 257,647 | $31.05 | $8.00M | 353,881 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-04-08 | 2016-04-11 | 400 | $71.40 | $28.6K | 96,234 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-04-08 | 2016-04-11 | 3,868 | $70.05 | $271.0K | 96,634 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-04-07 | 2016-04-11 | 13,000 | $72.15 | $938.0K | 109,794 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-04-07 | 2016-04-11 | 6,820 | $75.57 | $515.4K | 100,502 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-04-07 | 2016-04-11 | 200 | $74.13 | $14.8K | 107,322 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-04-07 | 2016-04-11 | 2,272 | $73.29 | $166.5K | 107,522 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-04-07 | 2016-04-11 | 99,981 | $71.44 | $7.14M | 122,794 | SEC↗ |
| Hove Anders D | Director | S Sale | 2016-04-07 | 2016-04-11 | 102,760 | $70.33 | $7.23M | 222,775 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise deriv | 2016-03-31 | 2016-04-04 | 30,000 | — | $0 | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise deriv | 2016-03-31 | 2016-04-04 | 24,000 | — | $0 | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise deriv | 2016-03-31 | 2016-04-04 | 7,500 | — | $0 | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise deriv | 2016-03-31 | 2016-04-04 | 12,500 | — | $0 | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise deriv | 2016-03-31 | 2016-04-04 | 15,000 | — | $0 | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise | 2016-03-31 | 2016-04-04 | 24,000 | $14.22 | $341.3K | 89,000 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise | 2016-03-31 | 2016-04-04 | 12,500 | $5.20 | $65.0K | 50,000 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise | 2016-03-31 | 2016-04-04 | 15,000 | $5.11 | $76.7K | 65,000 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise | 2016-03-31 | 2016-04-04 | 7,500 | $6.74 | $50.5K | 37,500 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | M Exercise | 2016-03-31 | 2016-04-04 | 30,000 | $6.92 | $207.6K | 30,000 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2016-03-22 | 2016-03-22 | 27,800 | $60.46 | $1.68M | 230,311 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2016-03-22 | 2016-03-22 | 9,700 | $59.89 | $580.9K | 258,111 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-03-02 | 2016-03-04 | 3,696 | $64.22 | $237.4K | 69,814 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-03-02 | 2016-03-04 | 1,875 | $63.56 | $119.2K | 73,510 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-03-02 | 2016-03-04 | 1,600 | $62.23 | $99.6K | 75,385 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-03-02 | 2016-03-04 | 1,829 | $64.88 | $118.7K | 67,985 | SEC↗ |
| Bell Graeme | Executive VP and CFO | A Award deriv | 2016-02-03 | 2016-02-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Bell Graeme | Executive VP and CFO | A Award deriv | 2016-02-03 | 2016-02-05 | 25,299 | — | $0 | 25,299 | SEC↗ |
| BERNS PAUL L | President and CEO | A Award deriv | 2016-02-03 | 2016-02-05 | 14,584 | — | $0 | 14,584 | SEC↗ |
| BERNS PAUL L | President and CEO | A Award deriv | 2016-02-03 | 2016-02-05 | 73,788 | — | $0 | 73,788 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | A Award deriv | 2016-02-03 | 2016-02-05 | 31,623 | — | $0 | 31,623 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | A Award deriv | 2016-02-03 | 2016-02-05 | 6,250 | — | $0 | 6,250 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | A Award deriv | 2016-02-03 | 2016-02-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | A Award deriv | 2016-02-03 | 2016-02-05 | 25,299 | — | $0 | 25,299 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | A Award deriv | 2016-02-03 | 2016-02-05 | 22,136 | — | $0 | 22,136 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | A Award deriv | 2016-02-03 | 2016-02-05 | 4,375 | — | $0 | 4,375 | SEC↗ |
| Bell Graeme | Executive VP and CFO | A Award | 2016-02-03 | 2016-02-05 | 5,000 | — | $0 | 11,006 | SEC↗ |
| BERNS PAUL L | President and CEO | A Award | 2016-02-03 | 2016-02-05 | 14,584 | — | $0 | 267,811 | SEC↗ |
| Sullivan Ryan T | EVP and General Counsel | A Award | 2016-02-03 | 2016-02-05 | 6,250 | — | $0 | 33,257 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | A Award | 2016-02-03 | 2016-02-05 | 5,000 | — | $0 | 76,985 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | A Award | 2016-02-03 | 2016-02-05 | 4,375 | — | $0 | 44,044 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2016-01-22 | 2016-01-25 | 11,800 | — | $0 | 0 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise | 2016-01-22 | 2016-01-25 | 11,800 | $7.55 | $89.1K | 39,081 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | M Exercise deriv | 2016-01-19 | 2016-01-21 | 20,000 | — | $0 | 61,000 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-01-19 | 2016-01-21 | 5,300 | $96.00 | $508.8K | 71,185 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-01-19 | 2016-01-21 | 200 | $96.95 | $19.4K | 70,985 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-01-19 | 2016-01-21 | 13,300 | $95.29 | $1.27M | 76,485 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-01-19 | 2016-01-21 | 1,200 | $93.92 | $112.7K | 89,785 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | M Exercise | 2016-01-19 | 2016-01-21 | 20,000 | $19.96 | $399.2K | 90,985 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2016-01-15 | 2016-01-19 | 1,466 | $89.57 | $131.3K | 27,281 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2016-01-04 | 2016-01-05 | 2,220 | $112.33 | $249.4K | 252,460 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2016-01-04 | 2016-01-05 | 80 | $110.97 | $8.9K | 254,680 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2016-01-04 | 2016-01-05 | 233 | $112.98 | $26.3K | 252,227 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | S Sale | 2016-01-04 | 2016-01-05 | 200 | $112.69 | $22.5K | 27,007 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | S Sale | 2016-01-04 | 2016-01-05 | 200 | $110.44 | $22.1K | 27,540 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | S Sale | 2016-01-04 | 2016-01-05 | 333 | $112.05 | $37.3K | 27,207 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-01-04 | 2016-01-05 | 100 | $110.76 | $11.1K | 71,740 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-01-04 | 2016-01-05 | 200 | $113.24 | $22.6K | 70,985 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2016-01-04 | 2016-01-05 | 555 | $112.21 | $62.3K | 71,185 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2015-12-15 | 2015-12-17 | 14,000 | — | $0 | 27,661 | SEC↗ |
| Hove Anders D | Director | S Sale | 2015-12-15 | 2015-12-17 | 900,000 | $111.25 | $100.13M | 325,535 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-12-15 | 2015-12-17 | 9,430 | $113.14 | $1.07M | 31,743 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-12-15 | 2015-12-17 | 1,574 | $112.06 | $176.4K | 41,173 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-12-15 | 2015-12-17 | 100 | $114.99 | $11.5K | 28,747 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-12-15 | 2015-12-17 | 2,896 | $113.79 | $329.5K | 28,847 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise | 2015-12-15 | 2015-12-17 | 14,000 | $5.59 | $78.3K | 42,747 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise deriv | 2015-12-11 | 2015-12-15 | 6,000 | — | $0 | 294,000 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise deriv | 2015-12-11 | 2015-12-15 | 14,000 | — | $0 | 0 | SEC↗ |
| Hove Anders D | Director | S Sale | 2015-12-11 | 2015-12-15 | 40,000 | $117.36 | $4.69M | 33,886 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-12-11 | 2015-12-15 | 590 | $115.52 | $68.2K | 274,170 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-12-11 | 2015-12-15 | 500 | $118.59 | $59.3K | 254,760 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-12-11 | 2015-12-15 | 8,178 | $117.60 | $961.7K | 255,260 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-12-11 | 2015-12-15 | 10,732 | $117.04 | $1.26M | 263,438 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise | 2015-12-11 | 2015-12-15 | 6,000 | $21.21 | $127.3K | 274,760 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise | 2015-12-11 | 2015-12-15 | 14,000 | $5.20 | $72.8K | 268,760 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | M Exercise deriv | 2015-12-10 | 2015-12-11 | 10,000 | — | $0 | 30,000 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | M Exercise | 2015-12-10 | 2015-12-11 | 10,000 | $15.30 | $153.0K | 37,740 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | S Sale | 2015-12-10 | 2015-12-11 | 1,100 | $108.90 | $119.8K | 36,640 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | S Sale | 2015-12-10 | 2015-12-11 | 4,900 | $110.25 | $540.2K | 31,740 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | S Sale | 2015-12-10 | 2015-12-11 | 4,000 | $111.03 | $444.1K | 27,740 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | M Exercise deriv | 2015-12-09 | 2015-12-11 | 20,000 | — | $0 | 81,000 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2015-12-09 | 2015-12-11 | 17,270 | $107.85 | $1.86M | 74,570 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2015-12-09 | 2015-12-11 | 2,730 | $108.22 | $295.4K | 71,840 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | M Exercise | 2015-12-09 | 2015-12-11 | 20,000 | $19.96 | $399.2K | 91,840 | SEC↗ |
| Hove Anders D | Director | S Sale | 2015-11-10 | 2015-11-12 | 100,295 | $103.60 | $10.39M | 1,598,517 | SEC↗ |
| Hove Anders D | Director | J Other | 2015-11-10 | 2015-11-12 | 73,092 | — | $0 | 73,886 | SEC↗ |
| Hove Anders D | Director | J Other | 2015-11-10 | 2015-11-12 | 372,982 | — | $0 | 1,225,535 | SEC↗ |
| Hove Anders D | Director | J Other | 2015-11-03 | 2015-11-05 | 1,500,000 | — | $0 | 1,225,535 | SEC↗ |
| Hove Anders D | Director | J Other | 2015-11-03 | 2015-11-05 | 372,982 | — | $0 | 1,598,517 | SEC↗ |
| Hove Anders D | Director | J Other | 2015-11-03 | 2015-11-12 | 372,982 | — | $0 | 1,698,812 | SEC↗ |
| Hove Anders D | Director | J Other | 2015-11-03 | 2015-11-12 | 1,399,705 | — | $0 | 1,325,830 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2015-09-15 | 2015-09-17 | 14,000 | — | $0 | 41,661 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise deriv | 2015-09-15 | 2015-09-17 | 4,000 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise deriv | 2015-09-15 | 2015-09-17 | 16,000 | — | $0 | 14,000 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise | 2015-09-15 | 2015-09-17 | 14,000 | $5.59 | $78.3K | 42,744 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-09-15 | 2015-09-17 | 11,199 | $139.85 | $1.57M | 30,045 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-09-15 | 2015-09-17 | 1,301 | $140.70 | $183.1K | 28,744 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-09-15 | 2015-09-17 | 1,500 | $139.00 | $208.5K | 41,244 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise | 2015-09-15 | 2015-09-17 | 4,000 | $5.11 | $20.4K | 258,760 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise | 2015-09-15 | 2015-09-17 | 16,000 | $5.20 | $83.2K | 274,760 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-09-15 | 2015-09-17 | 1,992 | $139.03 | $276.9K | 272,768 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-09-15 | 2015-09-17 | 16,209 | $139.83 | $2.27M | 256,559 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-09-15 | 2015-09-17 | 1,799 | $140.64 | $253.0K | 254,760 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise deriv | 2015-08-13 | 2015-08-17 | 20,000 | — | $0 | 4,000 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-08-13 | 2015-08-17 | 3,489 | $137.52 | $479.8K | 269,616 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-08-13 | 2015-08-17 | 11,575 | $139.45 | $1.61M | 254,760 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-08-13 | 2015-08-17 | 1,655 | $136.49 | $225.9K | 273,105 | SEC↗ |
| BERNS PAUL L | President and CEO | M Exercise | 2015-08-13 | 2015-08-17 | 20,000 | $5.11 | $102.2K | 274,760 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-08-13 | 2015-08-17 | 3,281 | $138.40 | $454.1K | 266,335 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2015-06-15 | 2015-06-17 | 7,661 | — | $0 | 33,239 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2015-06-15 | 2015-06-17 | 4,339 | — | $0 | 55,661 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise | 2015-06-15 | 2015-06-17 | 7,661 | $6.92 | $53.0K | 35,817 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise | 2015-06-15 | 2015-06-17 | 4,339 | $5.59 | $24.3K | 32,495 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-06-15 | 2015-06-17 | 7,661 | $69.05 | $529.0K | 28,156 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-06-15 | 2015-06-17 | 4,339 | $69.05 | $299.6K | 28,156 | SEC↗ |
| Hove Anders D | Director | A Award deriv | 2015-06-09 | 2015-06-11 | 4,096 | — | $0 | 4,096 | SEC↗ |
| Shapiro Lucy | Director | A Award deriv | 2015-06-09 | 2015-06-11 | 4,096 | — | $0 | 4,096 | SEC↗ |
| LESCHLY MARK | Director | A Award deriv | 2015-06-09 | 2015-06-11 | 4,096 | — | $0 | 4,096 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | A Award deriv | 2015-06-09 | 2015-06-11 | 4,403 | — | $0 | 4,403 | SEC↗ |
| Leonard Keith R | Director | A Award deriv | 2015-06-09 | 2015-06-11 | 4,096 | — | $0 | 4,096 | SEC↗ |
| WIERENGA WENDALL | Director | A Award deriv | 2015-06-09 | 2015-06-11 | 4,096 | — | $0 | 4,096 | SEC↗ |
| Hove Anders D | Director | A Award | 2015-06-09 | 2015-06-11 | 794 | — | $0 | 794 | SEC↗ |
| Shapiro Lucy | Director | A Award | 2015-06-09 | 2015-06-11 | 794 | — | $0 | 794 | SEC↗ |
| LESCHLY MARK | Director | A Award | 2015-06-09 | 2015-06-11 | 794 | — | $0 | 794 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | A Award | 2015-06-09 | 2015-06-11 | 853 | — | $0 | 853 | SEC↗ |
| Leonard Keith R | Director | A Award | 2015-06-09 | 2015-06-11 | 794 | — | $0 | 794 | SEC↗ |
| WIERENGA WENDALL | Director | A Award | 2015-06-09 | 2015-06-11 | 794 | — | $0 | 794 | SEC↗ |
| Bell Graeme | Executive VP and CFO | A Award deriv | 2015-06-01 | 2015-06-03 | 8,008 | — | $0 | 8,008 | SEC↗ |
| Bell Graeme | Executive VP and CFO | A Award deriv | 2015-06-01 | 2015-06-03 | 28,793 | — | $0 | 28,793 | SEC↗ |
| Bell Graeme | Executive VP and CFO | A Award deriv | 2015-06-01 | 2015-06-03 | 4,004 | — | $0 | 4,004 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-06-01 | 2015-06-02 | 100 | $71.72 | $7.2K | 7,220 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-06-01 | 2015-06-02 | 500 | $70.03 | $35.0K | 7,320 | SEC↗ |
| Bell Graeme | Executive VP and CFO | A Award | 2015-06-01 | 2015-06-03 | 6,006 | — | $0 | 6,006 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | S Sale | 2015-05-15 | 2015-05-15 | 8,920 | $63.73 | $568.5K | 17,840 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | S Sale | 2015-05-14 | 2015-05-14 | 6,000 | $63.76 | $382.6K | 7,020 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise deriv | 2015-05-13 | 2015-05-14 | 11,387 | — | $0 | 18,613 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise deriv | 2015-05-13 | 2015-05-14 | 15,666 | — | $0 | 31,334 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise deriv | 2015-05-13 | 2015-05-14 | 14,715 | — | $0 | 10,285 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise | 2015-05-13 | 2015-05-14 | 14,715 | $5.59 | $82.3K | 27,735 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | S Sale | 2015-05-13 | 2015-05-14 | 14,715 | $62.09 | $913.7K | 13,020 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise | 2015-05-13 | 2015-05-14 | 15,666 | $17.14 | $268.5K | 28,686 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | S Sale | 2015-05-13 | 2015-05-14 | 15,666 | $63.19 | $989.9K | 13,020 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise | 2015-05-13 | 2015-05-14 | 11,387 | $12.49 | $142.2K | 24,407 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | S Sale | 2015-05-13 | 2015-05-14 | 11,387 | $63.20 | $719.7K | 13,020 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise deriv | 2015-05-12 | 2015-05-14 | 279 | — | $0 | 5,721 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise deriv | 2015-05-12 | 2015-05-14 | 13,895 | — | $0 | 15,105 | SEC↗ |
| Maples Kirk R | SVP, Program Management | M Exercise deriv | 2015-05-12 | 2015-05-14 | 6,060 | — | $0 | 12,148 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | S Sale | 2015-05-12 | 2015-05-14 | 279 | $62.05 | $17.3K | 13,020 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise | 2015-05-12 | 2015-05-14 | 279 | $6.92 | $1.9K | 13,299 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | S Sale | 2015-05-12 | 2015-05-14 | 13,895 | $62.05 | $862.2K | 13,020 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | M Exercise | 2015-05-12 | 2015-05-14 | 13,895 | $6.96 | $96.7K | 26,915 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-05-12 | 2015-05-14 | 1,160 | $61.50 | $71.3K | 7,820 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-05-12 | 2015-05-14 | 4,900 | $60.97 | $298.8K | 8,980 | SEC↗ |
| Maples Kirk R | SVP, Program Management | M Exercise | 2015-05-12 | 2015-05-14 | 6,060 | $6.92 | $41.9K | 13,880 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-05-01 | 2015-05-01 | 500 | $54.14 | $27.1K | 7,820 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-05-01 | 2015-05-01 | 100 | $52.99 | $5.3K | 8,320 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | S Sale | 2015-04-29 | 2015-05-01 | 3,125 | $53.61 | $167.5K | 27,740 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-04-27 | 2015-04-28 | 9,750 | $63.85 | $622.5K | 253,760 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-04-27 | 2015-04-28 | 3,448 | $62.68 | $216.1K | 263,510 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-04-27 | 2015-04-28 | 2,100 | $61.74 | $129.7K | 266,958 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-04-27 | 2015-04-28 | 2,078 | $60.46 | $125.6K | 269,058 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-04-27 | 2015-04-28 | 7,624 | $59.79 | $455.8K | 271,136 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-04-24 | 2015-04-28 | 16,267 | $65.51 | $1.07M | 279,660 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-04-24 | 2015-04-28 | 7,833 | $64.69 | $506.7K | 295,927 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-04-24 | 2015-04-28 | 900 | $66.31 | $59.7K | 278,760 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | S Sale | 2015-04-15 | 2015-04-17 | 8,920 | $62.81 | $560.3K | 26,760 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-04-01 | 2015-04-03 | 600 | $57.02 | $34.2K | 8,420 | SEC↗ |
| Parker Geoffrey M. | Executive Vice President & C | P Buy | 2015-03-23 | 2015-03-23 | 3,000 | $52.43 | $157.3K | 173,000 | SEC↗ |
| BERNS PAUL L | President and CEO | G Gift | 2015-03-20 | 2015-04-28 | 5,000 | — | $0 | 303,760 | SEC↗ |
| BERNS PAUL L | President and CEO | S Sale | 2015-03-19 | 2015-03-23 | 37,500 | $56.07 | $2.10M | 308,760 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2015-03-16 | 2015-03-18 | 12,000 | $6.92 | $83.0K | 40,900 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise | 2015-03-16 | 2015-03-18 | 12,000 | $6.92 | $83.0K | 40,156 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-03-16 | 2015-03-18 | 7,900 | $56.27 | $444.5K | 32,256 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | S Sale | 2015-03-16 | 2015-03-18 | 4,100 | $56.76 | $232.7K | 28,156 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | S Sale | 2015-03-16 | 2015-03-18 | 8,920 | $55.60 | $496.0K | 35,680 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | M Exercise deriv | 2015-03-04 | 2015-03-04 | 48 | $7.55 | $362 | 13,552 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | M Exercise deriv | 2015-03-04 | 2015-03-04 | 4,952 | $7.25 | $35.9K | 0 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | M Exercise | 2015-03-04 | 2015-03-04 | 48 | $7.55 | $362 | 29,135 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | S Sale | 2015-03-04 | 2015-03-04 | 4,952 | $45.00 | $222.8K | 29,087 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | M Exercise | 2015-03-04 | 2015-03-04 | 4,952 | $7.25 | $35.9K | 34,039 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | S Sale | 2015-03-04 | 2015-03-04 | 48 | $45.00 | $2.2K | 29,087 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2015-03-03 | 2015-03-04 | 7,846 | $43.81 | $343.7K | 71,757 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | S Sale | 2015-03-03 | 2015-03-04 | 1,154 | $44.34 | $51.2K | 70,603 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-03-02 | 2015-03-04 | 600 | $43.95 | $26.4K | 9,020 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | S Sale | 2015-03-02 | 2015-03-04 | 400 | $44.60 | $17.8K | 44,600 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | S Sale | 2015-03-02 | 2015-03-04 | 6,475 | $43.99 | $284.8K | 45,000 | SEC↗ |
| BERNS PAUL L | President and CEO | A Award deriv | 2015-02-03 | 2015-02-05 | 84,100 | — | $0 | 84,100 | SEC↗ |
| BERNS PAUL L | President and CEO | A Award deriv | 2015-02-03 | 2015-02-05 | 12,890 | — | $0 | 12,890 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | A Award deriv | 2015-02-03 | 2015-02-05 | 28,400 | — | $0 | 28,400 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | A Award deriv | 2015-02-03 | 2015-02-05 | 6,930 | — | $0 | 6,930 | SEC↗ |
| Parker Geoffrey M. | Executive Vice President & C | A Award deriv | 2015-02-03 | 2015-02-05 | 6,930 | — | $0 | 6,930 | SEC↗ |
| Parker Geoffrey M. | Executive Vice President & C | A Award deriv | 2015-02-03 | 2015-02-05 | 28,400 | — | $0 | 28,400 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | A Award deriv | 2015-02-03 | 2015-02-05 | 20,845 | — | $0 | 20,845 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | A Award deriv | 2015-02-03 | 2015-02-05 | 1,475 | — | $0 | 1,475 | SEC↗ |
| Maples Kirk R | SVP, Program Management | A Award deriv | 2015-02-03 | 2015-02-05 | 1,475 | — | $0 | 1,475 | SEC↗ |
| Maples Kirk R | SVP, Program Management | A Award deriv | 2015-02-03 | 2015-02-05 | 20,845 | — | $0 | 20,845 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | A Award deriv | 2015-02-03 | 2015-02-05 | 20,845 | — | $0 | 20,845 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | A Award deriv | 2015-02-03 | 2015-02-05 | 1,475 | — | $0 | 1,475 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | A Award deriv | 2015-02-03 | 2015-02-05 | 1,475 | — | $0 | 1,475 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | A Award deriv | 2015-02-03 | 2015-02-05 | 20,845 | — | $0 | 20,845 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | A Award deriv | 2015-02-03 | 2015-02-05 | 24,360 | — | $0 | 24,360 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | A Award deriv | 2015-02-03 | 2015-02-05 | 6,350 | — | $0 | 6,350 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | A Award deriv | 2015-02-03 | 2015-02-05 | 24,360 | — | $0 | 24,360 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | A Award deriv | 2015-02-03 | 2015-02-05 | 6,350 | — | $0 | 6,350 | SEC↗ |
| BERNS PAUL L | President and CEO | A Award | 2015-02-03 | 2015-02-05 | 20,260 | — | $0 | 346,260 | SEC↗ |
| IPPOLITO VINCENT P | EVP & Chief Commercial Offic | A Award | 2015-02-03 | 2015-02-05 | 6,840 | — | $0 | 79,603 | SEC↗ |
| Parker Geoffrey M. | Executive Vice President & C | A Award | 2015-02-03 | 2015-02-05 | 6,840 | — | $0 | 94,840 | SEC↗ |
| Chanda Sanjay | SVP, Drug Development | A Award | 2015-02-03 | 2015-02-05 | 5,020 | — | $0 | 29,087 | SEC↗ |
| Maples Kirk R | SVP, Program Management | A Award | 2015-02-03 | 2015-02-05 | 5,020 | — | $0 | 9,620 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | A Award | 2015-02-03 | 2015-02-05 | 5,020 | — | $0 | 5,020 | SEC↗ |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assu | A Award | 2015-02-03 | 2015-02-05 | 5,020 | — | $0 | 13,020 | SEC↗ |
| Sullivan Ryan T | Sr. VP and General Counsel | A Award | 2015-02-03 | 2015-02-05 | 5,865 | — | $0 | 30,865 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | A Award | 2015-02-03 | 2015-02-05 | 5,865 | — | $0 | 28,156 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | S Sale | 2015-02-02 | 2015-02-04 | 6,875 | $37.35 | $256.8K | 51,475 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-02-02 | 2015-02-04 | 600 | $37.41 | $22.4K | 4,600 | SEC↗ |
| Maples Kirk R | SVP, Program Management | S Sale | 2015-01-02 | 2015-01-06 | 600 | $31.96 | $19.2K | 4,200 | SEC↗ |
| Plattner Jacob j | Senior VP, Research | S Sale | 2015-01-02 | 2015-01-06 | 6,875 | $32.09 | $220.6K | 58,350 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2014-12-29 | 2014-12-31 | 8,333 | $7.25 | $60.4K | 7,666 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2014-12-29 | 2014-12-31 | 2,708 | $7.25 | $19.6K | 5,291 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise deriv | 2014-12-29 | 2014-12-31 | 3,250 | $5.00 | $16.3K | 3,849 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise | 2014-12-29 | 2014-12-31 | 3,250 | $5.00 | $16.3K | 10,250 | SEC↗ |
| Zane Lee | SVP and Chief Medical Office | M Exercise | 2014-12-29 | 2014-12-31 | 8,333 | $7.25 | $60.4K | 18,583 | SEC↗ |